AAPL   380.07 (-0.34%)
MSFT   212.50 (-0.16%)
FB   240.54 (-1.25%)
GOOGL   1,501.10 (-0.17%)
AMZN   3,087.99 (+0.22%)
NVDA   411.47 (+0.69%)
CGC   15.65 (-4.16%)
BABA   257.62 (-0.02%)
MU   48.97 (-1.49%)
GE   6.61 (-3.64%)
TSLA   1,361.91 (-0.29%)
T   29.46 (-3.28%)
ACB   11.53 (-5.18%)
F   5.85 (-3.94%)
GILD   74.23 (-1.83%)
DIS   115.76 (-0.77%)
BAC   22.45 (-2.81%)
NFLX   497.89 (-0.97%)
BA   174.85 (-2.91%)
AAPL   380.07 (-0.34%)
MSFT   212.50 (-0.16%)
FB   240.54 (-1.25%)
GOOGL   1,501.10 (-0.17%)
AMZN   3,087.99 (+0.22%)
NVDA   411.47 (+0.69%)
CGC   15.65 (-4.16%)
BABA   257.62 (-0.02%)
MU   48.97 (-1.49%)
GE   6.61 (-3.64%)
TSLA   1,361.91 (-0.29%)
T   29.46 (-3.28%)
ACB   11.53 (-5.18%)
F   5.85 (-3.94%)
GILD   74.23 (-1.83%)
DIS   115.76 (-0.77%)
BAC   22.45 (-2.81%)
NFLX   497.89 (-0.97%)
BA   174.85 (-2.91%)
AAPL   380.07 (-0.34%)
MSFT   212.50 (-0.16%)
FB   240.54 (-1.25%)
GOOGL   1,501.10 (-0.17%)
AMZN   3,087.99 (+0.22%)
NVDA   411.47 (+0.69%)
CGC   15.65 (-4.16%)
BABA   257.62 (-0.02%)
MU   48.97 (-1.49%)
GE   6.61 (-3.64%)
TSLA   1,361.91 (-0.29%)
T   29.46 (-3.28%)
ACB   11.53 (-5.18%)
F   5.85 (-3.94%)
GILD   74.23 (-1.83%)
DIS   115.76 (-0.77%)
BAC   22.45 (-2.81%)
NFLX   497.89 (-0.97%)
BA   174.85 (-2.91%)
AAPL   380.07 (-0.34%)
MSFT   212.50 (-0.16%)
FB   240.54 (-1.25%)
GOOGL   1,501.10 (-0.17%)
AMZN   3,087.99 (+0.22%)
NVDA   411.47 (+0.69%)
CGC   15.65 (-4.16%)
BABA   257.62 (-0.02%)
MU   48.97 (-1.49%)
GE   6.61 (-3.64%)
TSLA   1,361.91 (-0.29%)
T   29.46 (-3.28%)
ACB   11.53 (-5.18%)
F   5.85 (-3.94%)
GILD   74.23 (-1.83%)
DIS   115.76 (-0.77%)
BAC   22.45 (-2.81%)
NFLX   497.89 (-0.97%)
BA   174.85 (-2.91%)
Log in

NASDAQ:KMPHKemPharm Insider Trades

$0.26
-0.02 (-7.06 %)
(As of 07/9/2020 10:49 AM ET)
Add
Compare
Today's Range
$0.24
Now: $0.26▼
$0.28
50-Day Range
$0.17
MA: $0.23▼
$0.30
52-Week Range
$0.12
Now: $0.26▼
$1.79
Volume1.34 million shs
Average Volume2.44 million shs
Market Capitalization$17.32 million
P/E RatioN/A
Dividend YieldN/A
Beta1.6

Insider Trades

KemPharm (NASDAQ:KMPH) Insider Buying and Selling Activity

Insider Ownership Percentage: 14.90%

Insider Buying and Selling by Quarter


KemPharm (NASDAQ KMPH) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/11/2020R. Laduane CliftonCFOBuy1,500$0.19$285.00
6/2/2020Travis C MickleCEOBuy110,000$0.18$19,800.00
5/26/2020R. Laduane CliftonCFOBuy11,500$0.19$2,185.00
3/25/2020R. Laduane CliftonCFOBuy1,000$0.22$220.0034,000  
3/13/2020Timothy J SangiovanniVPBuy4,000$0.20$800.0018,000  
3/11/2020R. Laduane CliftonCFOBuy8,000$0.25$2,000.0033,000  
3/9/2020Timothy J SangiovanniVPBuy333$0.25$83.256,333  
3/5/2020Travis C MickleCEOBuy25,000$0.31$7,750.00
12/31/2019Gordon K JohnsonInsiderBuy20,000$0.41$8,200.00
12/27/2019R. Laduane CliftonCFOBuy12,250$0.42$5,145.0017,750  
9/25/2019R. Laduane CliftonCFOBuy3,650$0.75$2,737.5012,750  
9/24/2019Timothy J SangiovanniVPBuy3,000$0.74$2,220.006,000  
9/24/2019Travis C MickleCEOBuy50,000$0.79$39,500.001,713,117  
9/16/2019R. Laduane CliftonCFOBuy5,000$0.89$4,450.004,200  
9/11/2019R. Laduane CliftonCFOBuy500$0.95$475.004,100  
9/9/2019Gordon K JohnsonInsiderBuy10,000$0.82$8,200.0012,000  
9/6/2019R. Laduane CliftonCFOBuy850$0.77$654.503,600  
10/12/2018Gordon K JohnsonInsiderBuy1,000$2.61$2,610.008,000  
10/12/2018Timothy J SangiovanniVPBuy3,000$2.53$7,590.001,500  
10/12/2018Travis C MickleCEOBuy5,000$2.55$12,750.001,679,978  
10/11/2018R. Laduane CliftonCFOBuy650$2.54$1,651.002,750  
10/10/2018Gordon K JohnsonInsiderBuy3,000$2.62$7,860.008,000  
10/5/2018Delaware Street Capital MasterMajor ShareholderBuy2,000,000$3.00$6,000,000.00  
7/30/2018Delaware Street Capital MasterMajor ShareholderBuy304,283$4.00$1,217,132.00  
5/31/2018R. Laduane CliftonCFOBuy525$6.10$3,202.50  
5/15/2018Daniel L CohenEVPBuy7,900$6.45$50,955.0035,500  
11/27/2017Daniel L CohenEVPBuy7,500$3.79$28,425.00  
9/25/2017R. Laduane CliftonCFOBuy300$3.78$1,134.001,575  
9/14/2017Delaware Street Capital MasterMajor ShareholderBuy325,888$3.27$1,065,653.76  
8/24/2017Daniel L CohenEVPBuy5,000$2.58$12,900.0025,000  
8/24/2017Gordon K JohnsonInsiderBuy4,000$2.60$10,400.003,000  
6/20/2017Travis C MickleCEOBuy8,000$3.45$27,600.001,629,612  
6/19/2017R. Laduane CliftonCFOBuy275$3.30$907.501,275  
5/25/2017Daniel L CohenEVPBuy2,500$4.11$10,275.0019,474  
3/31/2017Daniel L CohenEVPBuy2,500$4.48$11,200.0016,500  
3/24/2017R. Laduane CliftonCFOBuy1,000$4.24$4,240.00900  
3/22/2017Travis C MickleCEOBuy2,000$4.10$8,200.001,526,081  
3/20/2017David S TierneyDirectorBuy1,000$4.20$4,200.006,000  
11/30/2016Daniel L CohenEVPBuy5,000$3.50$17,500.0010,747  
9/6/2016Daniel L CohenEVPBuy10,000$4.75$47,500.001,310  
8/17/2016Travis C MickleCEOBuy5,000$4.95$24,750.001,381,176  
3/29/2016Travis C MickleCEOBuy2,450$14.57$35,696.501,381,176  
(Data available from 1/1/2013 forward)
This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.